Targeting tau protein in Alzheimer's disease

被引：12
|
作者：
Rafii, Michael S. [1 ,2 ]
机构：
[1] Univ Southern Calif, Alzheimers Therapeut Res Inst, Los Angeles, CA 90089 USA
[2] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92121 USA
来源：
LANCET | 2016年 / 388卷 / 10062期
关键词：
MILD; AGGREGATION; TRIALS; SOLANEZUMAB; MODELS;
D O I：
10.1016/S0140-6736(16)32107-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2842 / 2844
页数：4
相关论文
共 50 条
  • [41] Tau protein and the paired helical filament of Alzheimer's disease
    Goedert, M
    Klug, A
    BRAIN RESEARCH BULLETIN, 1999, 50 (5-6) : 469 - 470
  • [42] Tau in Alzheimer's disease
    Mandelkow, EM
    Mandelkow, E
    TRENDS IN CELL BIOLOGY, 1998, 8 (11) : 425 - 427
  • [43] CSF total tau, Aβ42 and phosphorylated tau protein as biomarkers for Alzheimer’s disease
    Kaj Blennow
    Eugeen Vanmechelen
    Harald Hampel
    Molecular Neurobiology, 2001, 24 : 87 - 97
  • [44] CSF total tau, aβ42 and phosphorylated tau protein as biomarkers for Alzheimer's disease
    Blennow, K
    Vanmechelen, E
    Hampel, H
    MOLECULAR NEUROBIOLOGY, 2001, 24 (1-3) : 87 - 97
  • [45] Beyond the neurotransmitter-focused approach in treating Alzheimer’s Disease: drugs targeting β-amyloid and tau protein
    Francesco Panza
    Vincenzo Solfrizzi
    Vincenza Frisardi
    Bruno P. Imbimbo
    Cristiano Capurso
    Alessia D’Introno
    Anna M. Colacicco
    Davide Seripa
    Gianluigi Vendemiale
    Antonio Capurso
    Alberto Pilotto
    Aging Clinical and Experimental Research, 2009, 21 : 386 - 406
  • [46] Beyond the neurotransmitter-focused approach in treating Alzheimer's Disease: drugs targeting β-amyloid and tau protein
    Panza, Francesco
    Solfrizzi, Vincenzo
    Frisardi, Vincenza
    Imbimbo, Bruno P.
    Capurso, Cristiano
    D'Introno, Alessia
    Colacicco, Anna M.
    Seripa, Davide
    Vendemiale, Gianluigi
    Capurso, Antonio
    Pilotto, Alberto
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2009, 21 (06) : 386 - 406
  • [47] Tau proteins and senescent Cells: Targeting aging pathways in Alzheimer's disease
    Singh, Mahaveer
    Ali, Haider
    Jyothi, S. Renuka
    Kaur, Irwanjot
    Kumar, Sachin
    Sharma, Naveen
    Prasad, G. V. Siva
    Pramanik, Atreyi
    Almalki, Waleed Hassan
    Imran, Mohd
    BRAIN RESEARCH, 2024, 1844
  • [48] Passive Immunotherapies Targeting Amyloid Beta and Tau Oligomers in Alzheimer's Disease
    Vander Zanden, Crystal M.
    Chi, Eva Y.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 109 (01) : 68 - 73
  • [49] Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
    Hong-Qi Y.
    Zhi-Kun S.
    Sheng-Di C.
    Translational Neurodegeneration, 1 (1)
  • [50] Targeting tau protein stability in alzheimer disease to identify novel therapeutic entry points
    Lasagna-Reeves, C.
    Al Ramahi, I.
    de Haro, M.
    Rousseaux, M.
    Kim, J.
    Jafar-Nejad, P.
    Vilanova-Velez, L.
    Westbrook, T.
    Botas, J.
    Zoghbi, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E131 - E131
12345